iRadimed Corporation IRMD

85.76 0.56 0.66% as of 25 Sep
Market cap
$1.1B
P/E
47.1×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
54.96 35.95 34.77 27.92 61.61 190.00 27.19 41.46 306.00 16.47
P/S ratio
14.77 9.51 9.09 6.71 13.64 8.72 6.85 8.65 7.05 3.73
P/FCF ratio
79.57 44.01 132.86 50.28 55.62 55.43 27.39 37.20 64.04 16.97
P/Operating CF
208.96 116.40 152.33 117.74 169.49 110.74 66.80 74.29 116.18 54.49
P/B ratio
13.08 8.03 8.34 4.86 7.90 4.50 4.75 6.27 4.94 3.80
EV/Sales
14.16 8.80 8.33 5.63 12.15 7.08 5.65 7.52 5.91 2.94
EV/EBITDA
43.44 28.29 26.26 18.40 45.26 385.25 21.99 32.18 52.60 8.04
EV/FCF
76.28 40.71 121.76 42.14 49.53 45.01 22.59 32.34 53.67 13.38
Current Ratio
7.98 8.84 4.65 9.06 11.18 12.96 10.06 9.50 8.61 9.25
Net Debt/EBITDA
(1.87) (2.29) (2.39) (3.56) (5.57) (89.20) (4.68) (4.84) (10.16) (2.16)
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
24.78% 24.31% 23.70% 17.59% 13.96% 2.34% 19.76% 16.84% 1.54% 22.61%
ROA
21.71% 20.20% 19.35% 15.24% 12.12% 1.99% 16.72% 14.42% 1.31% 19.92%
ROIC
37.60% 39.69% 57.82% 62.16% 63.44% (5.02%) 58.28% 49.58% 12.19% 109.91%
Return on Tangible Assets
23.69% 23.02% 24.93% 17.98% 13.04% 2.25% 17.46% 15.11% 1.52% 22.79%
Average Days of Receivables
59.52 52.61 68.06 90.90 44.84 52.65 69.11 50.48 59.76 42.41
Earnings Yield
1.82% 2.78% 2.88% 3.58% 1.62% 0.53% 3.68% 2.41% 0.33% 6.07%
Free Cash Flow Yield
1.26% 2.27% 0.75% 1.99% 1.80% 1.80% 3.65% 2.69% 1.56% 5.89%
Free Cash Flow per Share
1.30 1.33 0.43 0.65 0.85 0.43 0.86 0.66 0.24 0.73
Book value per Share
7.44 6.85 5.67 5.86 5.85 5.06 4.92 3.90 3.10 2.95
Free Cash Flow
16.53 16.81 5.46 8.17 10.52 5.18 9.75 7.11 2.59 7.88
EV/EBIT
45.38 29.35 27.26 19.19 51.74 0.00 25.16 38.11 106.17 8.74
Other line items

Show all line items

Columns are period end dates